Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.56 |
| ▸ | CA1 | P00915 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 5/20 | 0.56 |
| ▸ | CA9 | Q16790 | 5/20 | 0.56 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.56 |
| ▸ | EHMT1 | Q9H9B1 | 3/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | GSDMD | P57764 | 2/20 | 0.56 |
| ▸ | CA4 | P22748 | 2/20 | 0.56 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.53 |
| ▸ | MGLL | Q99685 | 5/20 | 0.53 |
| ▸ | ALDH2 | P05091 | 4/20 | 0.53 |
| ▸ | PHGDH | O43175 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9665272 | 0.83 | TAS2R38 (0.53) | CA12CA1CA2CA9EHMT2 | |
| SCHEMBL9665479 | 0.81 | CA12 (0.46) | CA12CA1CA2CA9EHMT2 | |
| SCHEMBL11866934 | 0.81 | CA12 (0.57) | CA12CA1CA2CA9EHMT2 | |
| SCHEMBL431669 | 0.78 | CA12 (0.43) | CA12CA1CA2CA9EHMT2 | |
| SCHEMBL8719555 | 0.77 | CA12 (0.56) | CA12CA1CA2CA9EHMT2 | |
| SCHEMBL7547953 | 0.74 | ALDH1A1 (0.45) | CA12CA1CA2CA9EHMT2 | |
| SCHEMBL9453353 | 0.74 | — | — | |
| SCHEMBL611243 | 0.74 | — | — | |
| SCHEMBL689792 | 0.74 | — | — | |
| SCHEMBL23892055 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118439936-A | Method for preparing anisic aldehyde by using p-methoxybenzyl chloride | 山东新和成药业有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-118440104-A | Boron-containing%10B) Preparation method of medicine BSH and intermediate thereof | 安徽普利药业有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-117064765-B | Dental adhesive restorative material composition and application thereof | 长春新斯达科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-115105416-B | Acrylic ester composite resin composition and preparation method and application thereof | 爱迪特（秦皇岛）科技股份有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-117064765-A | Dental adhesive restorative material composition and application thereof | 长春新斯达科技有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-115427475-A | Oxidizable-reducing curing composition and preparation method thereof | 汉高股份有限及两合公司 | 2022-12-02 | — | — | CN | claimed |
| CN-115105416-A | Acrylate composite resin composition and preparation method and application thereof | 爱迪特（秦皇岛）科技股份有限公司 | 2022-09-27 | — | — | CN | claimed |
| US-10025005-B2 | Composition for optical materials | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-07-17 | — | — | US | claimed |
| US-9793566-B2 | Aqueous electrolytes for redox flow battery systems | BATTELLE MEMORIAL INSTITUTE (US) | 2017-10-17 | — | — | US | claimed |
| US-20160308233-A1 | AQUEOUS ELECTROLYTES FOR REDOX FLOW BATTERY SYSTEMS | BATTELLE MEMORIAL INSTITUTE (US) | 2016-10-20 | — | — | US | claimed |
| EP-1716197-B1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF SE (DE) | 2008-10-29 | — | — | EP | claimed |
| US-7153411-B2 | Method for cleaning and polishing metallic alloys and articles cleaned or polished thereby | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-12-26 | — | — | US | claimed |
| US-6982288-B2 | Dental cements, filling materials, adhesives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-01-03 | — | — | US | claimed |
| JP-2005524682-A | — | — | 2005-08-18 | — | — | JP | claimed |
| EP-1496837-A1 | MEDICAL COMPOSITIONS CONTAINING AN IONIC SALT | 3M Innovative Properties Company (US) | 2005-01-19 | — | — | EP | claimed |
| WO-2003086328-A1 | MEDICAL COMPOSITIONS CONTAINING AN IONIC SALT | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030195273-A1 | Medical compositions containing an ionic salt, kits, and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2003-10-16 | — | — | US | claimed |
| US-5147905-A | Cationic polyepoxide and epoxy resins for electrodeposition; flexibility; workability | THE DOW CHEMICAL COMPANY (US) | 1992-09-15 | — | — | US | claimed |
| EP-0483352-A1 | ADVANCED AND UNADVANCED EPOXY RESIN COMPOSITIONS, NUCLEOPHILIC DERIVATIVES THEREOF AND CURABLE AND COATING COMPOSITIONS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1992-05-06 | — | — | EP | claimed |
| WO-1991018034-A1 | ADVANCED AND UNADVANCED COMPOSITIONS, NUCLEOPHILIC DERIVATIVES THEREOF AND CURABLE AND COATING COMPOSITIONS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1991-11-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10025005-B2 | Composition for optical materials | CRYZ, CRYAA, CRYAB | CA12 1953/4885CA1 1773/4885CA2 1192/4885 |
| US-20030195273-A1 | Medical compositions containing an ionic salt, kits, and methods | NOX4, SCN4A, IL4 | CA12 158/4885CA1 96/4885CA2 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.